Andres Fajardo

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) reported its financial results late Monday for the fourth quarter and full year concluded on December 31, 2023.  The company reported a 6% increase in revenue compared to the previous year, driven by a notable 39% rise...

Clever Leaves Holdings Inc. (NASDAQ:CLVR), has been granted Australian GMP certification for its facilities in Colombia by the Therapeutic Goods Administration (TGA). The certification authorizes Clever Leaves to manufacture cannabis products for medical marijuana patients in Australia, the...

Amid challenges faced by the global cannabis market, Clever Leaves Holdings (NASDAQ: CLVR) (NASDAQ: CLVRW) has made a decisive move to maintain its listing on the U.S. stock exchange. "As a result of the Reverse Share Split, every 30 common shares of the Company will automatically be...

Clever Leaves Holdings Inc. (NASDAQ: CLVR), a multinational cannabis company, announced its financial and operational results late Monday for the second quarter ending June 30, 2023. 21% Revenue Boost The company reported a 21% year-over-year increase in revenue, driven by a remarkable...

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) announced that its Colombian flower is now available to patients in Australia through a partnership with Australian Natural Therapeutics Group (ANTG). The products are available to medical patients in Australia under ANTG’s “...

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) has closed the sale of the assets, including lab and processing equipment, previously used in its EU-GMP certified cannabis processing facility in Setúbal, Portugal, as controlled by its wholly owned subsidiary, Clever Leaves...

Global medicinal cannabis company Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) recently completed its inaugural shipment of medical cannabis extracts from Colombia to its partner, Astrasana Holding AG in Switzerland. This milestone marks Clever Leaves' entry into...

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) has entered into a five-year agreement with SOMAÍ Pharmaceuticals, to supply its operations in Portugal with EU-GMP certified CBD extracts from Colombia. With the first shipments under the agreement already completed, Clever Leaves...

Global medicinal cannabis company Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) reported late Thursday its financial and operating results for the first quarter of 2023. CEO Andres Fajardo highlighted the continued commercial momentum in core target markets such as Brazil,...

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NADAQ:CLVRW) has entered into a five-year agreement with Hypera Pharma (B3:HYPE3) to supply Clever Leaves’ CBD-dominant oral solutions with the aim of treating various medical conditions and prescribing to Brazilian patients. Hypera Pharma is one of...

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) announced its commercial agreement with US-based Praetorian Global Inc., to produce cannabis flower and downstream products from Clever Leaves cultivation facility in Colombia for distribution globally. Flower products resulting from the...

Clever Leaves Holdings Inc, (NASDAQ: CLVR) reported its financial and operating results on Thursday for the fourth quarter and full year ended December 31, 2022. Fourth Quarter and full year 2022 revenue increased 71% and 90%, respectively. Total annual revenue growth...

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) announced the wind-down of all operations in Portugal as part of its ongoing restructuring initiatives. Under this restructuring plan, the company expects its Portuguese flower cultivation, post-harvest processes, and manufacturing...

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) Q3 2022 revenue was $3.3 million, a 18% decrease compared to $4.0 million in Q3 2021. Q3 2022 vs. Q3 2021 Gross profit was $280,000, which included a $1.7 million inventory provision, compared to $1.9 million, which included a $0.7...

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) announced that its partner, Peruvian medicinal cannabis company Anden Naturals, has obtained the sanitary registration for the finished product, “Andenol 50,” a 5% THC dominant oral solution produced by Clever Leaves in Colombia...